Kazuaki Hashiguchi's questions to Takeda Pharmaceutical Co Ltd (TAK) leadership • Q3 2025
Question
Kazuaki Hashiguchi of Daiwa Securities asked for Takeda's perspective on potential changes in the U.S. business environment, including PBM redesign and geopolitical tariffs, and their potential impact on the business.
Answer
CEO Christophe Weber acknowledged the changing U.S. environment, including bipartisan support for the IRA, but stressed the market remains vital for innovation. He noted that while there are positives like the Medicare out-of-pocket cap, risks like trade tariffs could require Takeda to adapt its global manufacturing network over time.